Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
94 studies found for:    Open Studies | "Dry Eye Syndromes"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients
Condition: Dry Eye Syndrome
Intervention: Device: Lacrima medical Prototypes
2 Recruiting Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
Condition: Dry Eye Syndromes
Interventions: Drug: Haporine-S;   Drug: Restasis (cyclosporine 0.05%)
3 Unknown  Treatment of Dry Eye With Supplements
Condition: Dry Eye Syndromes
Intervention: Dietary Supplement: Vitamac® Tag and Nacht capsules
4 Recruiting Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Syndrome
Intervention: Drug: dexamethasone, artificial tears
5 Recruiting Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome
Conditions: Meibomian Gland Dysfunction;   Dry Eye Syndrome
Interventions: Device: Cutera Xeo Platform-Limelight;   Device: Sciton BroadBand Light
6 Recruiting Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Device: T2762;   Device: Vismed®
7 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
8 Recruiting Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye
Condition: Dry Eye Syndromes
Intervention: Device: Oculeve Intranasal Lacrimal Neurostimulator
9 Unknown  A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention: Drug: Essential fatty acid supplement
10 Recruiting Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Conditions: Primary Sjogren Syndrome;   Secondary Sjogren Syndrome;   Aqueous Deficient Dry Eye Disease;   Evaporative Dry Eye Disease
Interventions: Drug: Restasis;   Drug: Refresh Endura
11 Recruiting Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Disease
Interventions: Drug: OTX-101 0.05%;   Drug: OTX-101 0.09%;   Drug: Vehicle
12 Unknown  Oral Nutrition Impact on Tear Film
Condition: Dry Eye Syndrome
Intervention: Dietary Supplement: Omega 3, Vitamins A, D3 and E
13 Unknown  Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
Conditions: Dry Eye;   Sjogren's Syndrome;   Graft vs. Host Disease
Intervention: Drug: Thymosin Beta 4 eye drops vs. vehicle
14 Recruiting The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease
Condition: Dry Eye Disease
Intervention: Dietary Supplement: Omega-3 (Triglyceride form)
15 Recruiting Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye
Condition: Dry Eye Syndrome.
Interventions: Biological: Human nerve growth factor 20 µg/mL;   Biological: Human nerve growth factor 4 µg/mL or 60 µg/mL
16 Unknown  Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
Condition: Dry Eye Syndromes
Interventions: Drug: Altaire Gel forming solution;   Drug: Refresh Tears
17 Recruiting Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain
Conditions: Ocular Pain;   Dry Eye Syndrome
Interventions: Drug: SYL1001;   Drug: Placebo
18 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole
19 Recruiting Civamide Nasal Solution for Dry Eye
Condition: Dry Eye
Intervention: Drug: Civamide Nasal Spray
20 Not yet recruiting Study of ACCS Eye Drops in Treating Dry Eye
Condition: Dry Eye Syndrome
Interventions: Drug: ACCS;   Drug: Refresh Lubricant Eye Drops

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years